200 related articles for article (PubMed ID: 14669039)
1. Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro.
Donald S; Verschoyle RD; Greaves P; Orr S; Jimeno J; Gescher AJ
Cancer Chemother Pharmacol; 2004 Apr; 53(4):305-12. PubMed ID: 14669039
[TBL] [Abstract][Full Text] [Related]
2. Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.
Donald S; Verschoyle RD; Greaves P; Gant TW; Colombo T; Zaffaroni M; Frapolli R; Zucchetti M; D'Incalci M; Meco D; Riccardi R; Lopez-Lazaro L; Jimeno J; Gescher AJ
Cancer Res; 2003 Sep; 63(18):5902-8. PubMed ID: 14522916
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat.
Donald S; Verschoyle RD; Edwards R; Judah DJ; Davies R; Riley J; Dinsdale D; Lopez Lazaro L; Smith AG; Gant TW; Greaves P; Gescher AJ
Cancer Res; 2002 Aug; 62(15):4256-62. PubMed ID: 12154027
[TBL] [Abstract][Full Text] [Related]
4. Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma.
Donald S; Verschoyle RD; Greaves P; Colombo T; Zucchetti M; Falcioni C; Zaffaroni M; D'Incalci M; Manson MM; Jimeno J; Steward WP; Gescher AJ
Int J Cancer; 2004 Oct; 111(6):961-7. PubMed ID: 15300810
[TBL] [Abstract][Full Text] [Related]
5. Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity.
Lee JK; Leslie EM; Zamek-Gliszczynski MJ; Brouwer KL
Toxicol Appl Pharmacol; 2008 Apr; 228(1):17-23. PubMed ID: 18191164
[TBL] [Abstract][Full Text] [Related]
6. Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: a toxicogenomics approach.
Kienhuis AS; Wortelboer HM; Hoflack JC; Moonen EJ; Kleinjans JC; van Ommen B; van Delft JH; Stierum RH
Drug Metab Dispos; 2006 Dec; 34(12):2083-90. PubMed ID: 16963487
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes.
Liu ZH; Zeng S
Toxicol Lett; 2009 Jun; 187(3):131-6. PubMed ID: 19429255
[TBL] [Abstract][Full Text] [Related]
8. 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity.
Verschoyle RD; Carthew P; Wolf CR; Dinsdale D
Toxicol Appl Pharmacol; 1993 Oct; 122(2):208-13. PubMed ID: 8212003
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production.
Allavena P; Signorelli M; Chieppa M; Erba E; Bianchi G; Marchesi F; Olimpio CO; Bonardi C; Garbi A; Lissoni A; de Braud F; Jimeno J; D'Incalci M
Cancer Res; 2005 Apr; 65(7):2964-71. PubMed ID: 15805300
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-naphthoflavone and phenobarbital on the nephrotoxicity of chlorotrifluoroethylene and 1,1-dichloro-2,2-difluoroethylene in the rat.
Morel G; Ban M; Bonnet P; Zissu D; Brondeau MT
J Appl Toxicol; 2005; 25(2):153-65. PubMed ID: 15744758
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.
Zelek L; Yovine A; Brain E; Turpin F; Taamma A; Riofrio M; Spielmann M; Jimeno J; Misset JL
Br J Cancer; 2006 Jun; 94(11):1610-4. PubMed ID: 16736024
[TBL] [Abstract][Full Text] [Related]
12. Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes.
Kocarek TA; Schuetz EG; Guzelian PS
Toxicol Appl Pharmacol; 1993 Jun; 120(2):298-307. PubMed ID: 8511800
[TBL] [Abstract][Full Text] [Related]
13. Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene.
Ratra GS; Cottrell S; Powell CJ
Toxicol Sci; 1998 Nov; 46(1):185-96. PubMed ID: 9928682
[TBL] [Abstract][Full Text] [Related]
14. In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction.
Brandon EF; Meijerman I; Klijn JS; den Arend D; Sparidans RW; Lázaro LL; Beijnen JH; Schellens JH
Anticancer Drugs; 2005 Oct; 16(9):935-43. PubMed ID: 16162970
[TBL] [Abstract][Full Text] [Related]
15. Effects of dimethyl diphenyl bicarboxylate on the metabolism and hepatotoxicity of aflatoxin B1 in rats.
Lu H; Li Y
Yao Xue Xue Bao; 2002 Oct; 37(10):753-7. PubMed ID: 12567855
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of diphenyl diselenide protects against cadmium-induced liver damage in rats.
Borges LP; Brandão R; Godoi B; Nogueira CW; Zeni G
Chem Biol Interact; 2008 Jan; 171(1):15-25. PubMed ID: 17950719
[TBL] [Abstract][Full Text] [Related]
17. Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
Jurima-Romet M; Huang HS
Biochem Pharmacol; 1992 Nov; 44(9):1803-10. PubMed ID: 1449535
[TBL] [Abstract][Full Text] [Related]
18. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
19. Diazinon-induced hepatotoxicity and protective effect of vitamin E on some biochemical indices and ultrastructural changes.
Kalender S; Ogutcu A; Uzunhisarcikli M; Açikgoz F; Durak D; Ulusoy Y; Kalender Y
Toxicology; 2005 Aug; 211(3):197-206. PubMed ID: 15925023
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity.
Bornheim LM
Toxicol Appl Pharmacol; 1998 May; 150(1):158-65. PubMed ID: 9630465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
